Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Response criteria in acute myeloid leukemia (AML) has recently been re-established, with morphologic examination utilized to determine whether patients have achieved complete remission (CR). Approximately half of the adult patients who entered CR will relapse within 12 months due to the outgrowth of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cloos, Jacqueline, Harris, Jeffrey R., Janssen, Jeroen J.W.M., Kelder, Angele, Huang, F., Sijm, Gerrit, Vonk, Maike, Snel, Alexander N., Scheick, Jennifer R., Scholten, Willemijn J., Carbaat-Ham, Jannemieke, Veldhuizen, Dennis, Hanekamp, Diana, Oussoren-Brockhoff, Yvonne J.M., Kaspers, Gertjan J.L., Schuurhuis, Gerrit J., Sasser, A. Kate, Ossenkoppele, Gert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MyJove Corporation 2018
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931431/
https://www.ncbi.nlm.nih.gov/pubmed/29553571
http://dx.doi.org/10.3791/56386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931431/
https://www.ncbi.nlm.nih.gov/pubmed/29553571
http://dx.doi.org/10.3791/56386

Ejemplares similares